An MD2 Hot-Spot-Mimicking Peptide that Suppresses TLR4-Mediated Inflammatory Response in vitro and in vivo
CHEMBIOCHEM (2011)
Journal
CHEMBIOCHEM
Volume 12, Issue 12, Pages 1827-1831Publisher
WILEY-V C H VERLAG GMBH
Keywords
Funding
- National Institutes of Health [DA026950, DA025740, NS067425, RR025780, DA029119, DA023132, DA024044]
- University of Colorado [NIH T32 GM-065103]
- Australian National Health and Medical Research Council [465423]
- Australian Research Council [DP110100297]
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Bisphenol A: A potential Toll-like receptor 4/myeloid differentiation factor 2 complex agonist
Wisurumuni Arachchilage Hasitha Maduranga Karunarathne, Ilandarage Menu Neelaka Molagoda, Yung Hyun Choi, Sang Rul Park, Seungheon Lee, Gi-Young Kim
ENVIRONMENTAL POLLUTION (2021)
L6H21 protects against cognitive impairment and brain pathologies via toll-like receptor 4-myeloid differentiation factor 2 signalling in prediabetic rats
Thura Tun Oo, Natticha Sumneang, Benjamin Ongnok, Busarin Arunsak, Titikorn Chunchai, Sasiwan Kerdphoo, Nattayaporn Apaijai, Wasana Pratchayasakul, Guang Liang, Nipon Chattipakorn, Siriporn C. Chattipakorn
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Mice Plasmacytoid Dendritic Cells Were Activated by Lipopolysaccharides Through Toll-Like Receptor 4/Myeloid Differentiation Factor 2
Wei Zhang, Eun-Koung An, Juyoung Hwang, Jun-O Jin
FRONTIERS IN IMMUNOLOGY (2021)
Chemical reagents modulate nucleic acid-activated toll-like receptors
Xiao Li, Xinyuan Sun, Xuemin Guo, Xueren Li, Shouchun Peng, Xin Mu
BIOMEDICINE & PHARMACOTHERAPY (2022)
Antimicrobial peptides could antagonize uncontrolled inflammation via Toll-like 4 receptor
Danieli F. Buccini, Beatriz C. Roriz, Julia M. Rodrigues, Octavio L. Franco
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2022)
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective
Yongsheng Zhang, Xinjie Liang, Xuefei Bao, Wei Xiao, Guoliang Chen
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)
Broad-spectrum coronavirus 3C-like protease peptidomimetic inhibitors effectively block SARS-CoV-2 replication in cells: Design, synthesis, biological evaluation, and X-ray structure determination
Irina Stefanelli, Angela Corona, Carmen Cerchia, Emilia Cassese, Salvatore Improta, Elisa Costanzi, Sveva Pelliccia, Stefano Morasso, Francesca Esposito, Annalaura Paulis, Sante Scognamiglio, Francesco Saverio Di Leva, Paola Storici, Margherita Brindisi, Enzo Tramontano, Rolando Cannalire, Vincenzo Summa
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2023)
C-terminal modified Enkephalin-like tetrapeptides with enhanced affinities at the kappa opioid receptor and monoamine transporters
Mehr-un-Nisa, Munawar A. Munawar, David Rankin, Victor J. Hruby, Frank Porreca, Yeon Sun Lee
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
KBE009: A Bestatin-Like Inhibitor of the Trypanosoma cruzi Acidic M17 Aminopeptidase with In Vitro Anti-Trypanosomal Activity
Jorge Gonzalez-Bacerio, Irina Arocha, Mirtha Elisa Aguado, Yanira Mendez, Sabrina Marsiccobetre, Maikel Izquierdo, Daniel G. Rivera, Katherine Figarella, Nestor L. Uzcategui
LIFE-BASEL (2021)
Myeloid differentiation factor 2 in the heart: Bench to bedside evidence for potential clinical benefits?
Natticha Sumneang, Nattayaporn Apaijai, Siriporn C. Chattipakorn, Nipon Chattipakorn
PHARMACOLOGICAL RESEARCH (2021)
Targeting Toll-like Receptor (TLR) Pathways in Inflammatory Arthritis: Two Better Than One?
Sandra Santos-Sierra
BIOMOLECULES (2021)
Albendazole induces the terminal differentiation of acute myeloid leukaemia cells to monocytes by stimulating the Kruppel-like factor 4-dihydropyrimidinase-like 2A (KLF4-DPYSL2A) axis
Mina Noura, Ken Morita, Hiroki Kiyose, Yukiko Okuno, Hidemasa Matsuo, Asami Koyama, Yoko Nishinaka-Arai, Yasuhiko Kamikubo, Souichi Adachi
BRITISH JOURNAL OF HAEMATOLOGY (2021)
Structural Diversity of Peptoids: Tube-Like Structures of Macrocycles
Claudine Nicole Herlan, Katharina Sommer, Patrick Weis, Martin Nieger, Stefan Brase
MOLECULES (2021)
The role of toll-like receptors in orchestrating osteogenic differentiation of mesenchymal stromal cells and osteoimmunology
Xiaoyang Liu, Zongke Zhou, Wei-Nan Zeng, Qin Zeng, Xingdong Zhang
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2023)
Peptides and Peptidomimetics as Inhibitors of Enzymes Involved in Fibrillar Collagen Degradation
Patrycja Ledwon, Anna Maria Papini, Paolo Rovero, Rafal Latajka
MATERIALS (2021)
Effects of Mild and Moderate Monoclonal Antibody Dose on Inflammation, Bone Loss, and Activation of the Central Nervous System in a Female Collagen Antibody-induced Arthritis Mouse Model
Bonnie Williams, Florence Lees, Helen Tsangari, Mark R. Hutchinson, Egon Perilli, Tania N. Crotti
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2021)
Neuroimmunological complications arising from chemotherapy-induced gut toxicity and opioid exposure in female dark agouti rats
Juliana Esma Bajic, Gordon Stanley Howarth, Suzanne Mashtoub, Alexandra Louise Whittaker, Larisa Bobrovskaya, Mark Rowland Hutchinson
JOURNAL OF NEUROSCIENCE RESEARCH (2022)
Evaluation of miRNA as Biomarkers of Emotional Valence in Pigs
Laura Marsh, Mark R. Hutchinson, Clive McLaughlan, Stefan T. Musolino, Michelle L. Hebart, Robyn Terry, Paul J. Verma, Stefan Hiendleder, Alexandra L. Whittaker
ANIMALS (2021)
Intrathecal implantation surgical considerations in rodents; a review
Azim Arman, Mark R. Hutchinson
JOURNAL OF NEUROSCIENCE METHODS (2021)
Autofluorescent imprint of chronic constriction nerve injury identified by deep learning
Martin E. Gosnell, Vasiliki Staikopoulos, Ayad G. Anwer, Saabah B. Mahbub, Mark R. Hutchinson, Sanam Mustafa, Ewa M. Goldys
NEUROBIOLOGY OF DISEASE (2021)
TLR4 biased small molecule modulators
Cong Lin, Hongshuang Wang, Miyuan Zhang, Sanam Mustafa, Yibo Wang, Hongyuan Li, Hang Yin, Mark R. Hutchinson, Xiaohui Wang
PHARMACOLOGY & THERAPEUTICS (2021)
Toll-like receptors change morphine-induced antinociception, tolerance and dependence: Studies using male and female TLR and signalling gene KO mice
Jacob H. L. Thomas, Liang Lui, Andrew Abell, William Tieu, Andrew A. Somogyi, Juliana E. Bajic, Mark R. Hutchinson
BRAIN BEHAVIOR AND IMMUNITY (2022)
Glial-modulating agents for the treatment of pain: protocol for a systematic review
Ian Gilron, Maggie Z. X. Xiao, Marielle Balanaser, Meg Carley, Nader Ghasemlou, Michael W. Salter, Mark R. Hutchinson, Dwight E. Moulin, R. Andrew Moore, Amanda Ross-White
BMJ OPEN (2022)
The Neuroimmune Interface and Chronic Pain Through the Lens of Production Animals
Charlotte H. Johnston, Alexandra L. Whittaker, Samantha H. Franklin, Mark R. Hutchinson
FRONTIERS IN NEUROSCIENCE (2022)
Study protocol: an observational study of distress, immune function and persistent pain in HIV
Victoria J. Madden, Ncumisa Msolo, Luyanduthando Mqadi, Maia Lesosky, Gillian J. Bedwell, Mark R. Hutchinson, Jonathan Grant Peter, Romy Parker, Andrew Schrepf, Robert R. Edwards, John A. Joska
BMJ OPEN (2022)
Considering Precision and Utility When we Talk About Pain. Comment on Cohen et al
Graham L. Moseley, Neil Pearson, Roland Reezigt, Victoria J. Madden, Mark R. Hutchinson, Martin Dunbar, Anneke J. Beetsma, Hayley B. Leake, Pete Moore, Laura Simons, Lauren Heathcote, Cormac Ryan, Carolyn Berryman, Amelia K. Mardon, Benedict M. Wand
JOURNAL OF PAIN (2023)
Long-term intrathecal administration of morphine vs. baclofen: Differences in CSF glycoconjugate profiles using multiglycomics
Edward S. X. Moh, Krishnatej Nishtala, Sameera Iqbal, Vasiliki Staikopoulos, Dilip Kapur, Mark R. Hutchinson, Nicolle H. Packer
GLYCOBIOLOGY (2022)
Evolving Expectations of the Orthopedic Team Physician: Managing the Sidelines and Landmines
Timothy L. Miller, Grant L. Jones, Mark Hutchinson, Dharmesh Vyas, James Borchers
CURRENT SPORTS MEDICINE REPORTS (2021)
Nicotine and its metabolite cotinine target MD2 and inhibit TLR4 signaling
Hongyuan Li, Yinghua Peng, Cong Lin, Xiaozheng Zhang, Tianshu Zhang, Yibo Wang, Yuanpeng Li, Siru Wu, Hongshuang Wang, Mark R. Hutchinson, Linda R. Watkins, Xiaohui Wang
INNOVATION (2021)
Androgens, Endometriosis and Pain
Susan F. Evans, M. Louise Hull, Mark R. Hutchinson, Paul E. Rolan
FRONTIERS IN REPRODUCTIVE HEALTH (2021)